NCT05087030: A reported trial by Gedeon Richter Plc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05087030 |
|---|---|
| Title | A Randomised, Double Blind, Multicentre Phase III Study to Assess the Efficacy and Safety of RGB-14-P Compared to Prolia® in Women With Postmenopausal Osteoporosis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 21, 2021 |
| Completion date | Oct. 2, 2023 |
| Required reporting date | Oct. 1, 2024, midnight |
| Actual reporting date | Sept. 27, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |